Log in

NASDAQ:ULBIUltralife Stock Price, Forecast & News

$6.94
+0.09 (+1.31 %)
(As of 08/7/2020 04:00 PM ET)
Add
Compare
Today's Range
$6.80
Now: $6.94
$6.97
50-Day Range
$6.27
MA: $6.82
$7.56
52-Week Range
$4.85
Now: $6.94
$9.48
Volume10,686 shs
Average Volume40,727 shs
Market Capitalization$110.30 million
P/E Ratio21.03
Dividend YieldN/A
Beta1.34
Ultralife Corporation designs, manufactures, installs, and maintains power, and communication and electronic systems for government, defense, and commercial sectors worldwide. The company operates in two segments, Battery & Energy Products and Communications Systems. The Battery & Energy Products segment offers lithium 9-volt, cylindrical, thin lithium manganese dioxide, rechargeable, and other non-rechargeable batteries; lithium ion cells, multi-kilowatt module lithium ion battery systems, and uninterruptable power supplies; and rugged military and commercial battery charging systems and accessories, including smart chargers, multi-bay charging systems, and various cables. The Communications Systems segment provides communications systems and accessories to support military communications systems, such as radio frequency amplifiers, power supplies and cables, connector assemblies, amplified speakers, equipment mounts, case equipment, man-portable systems, and integrated communication systems for fixed or vehicle applications comprising vehicle adapters, vehicle installed power enhanced rifleman appliqué systems, and SATCOM systems. The segment's military communications systems and accessories are designed to enhance and extend the operation of communications equipment, such as vehicle-mounted, manpack, and handheld transceivers. It sells its products under the Ultralife, Lithium Power, McDowell Research, AMTI, ABLE, ACCUTRONICS, ACCUPRO, and ENTELLION brands through original equipment manufacturers, and industrial and defense supply distributors, as well as directly to the United States and international defense departments. In addition, the company sells its 9-volt battery to the broader consumer market through national and regional retail chains and Internet retailers. Ultralife Corporation was founded in 1990 and is headquartered in Newark, New York.
Read More
Ultralife logo

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.3Dividend Strength: 0.0Insider Behavior: 5.0Valuation: 1.3 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.71 out of 5 stars


Industry, Sector and Symbol

Industry Miscellaneous electrical machinery, equipment, & supplies
Sub-IndustryN/A
Current SymbolNASDAQ:ULBI
CUSIPN/A
Phone315-332-7100

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$106.79 million
Cash Flow$0.58 per share
Book Value$7.07 per share

Profitability

Net Income$5.20 million

Miscellaneous

EmployeesN/A
Market Cap$110.30 million
Next Earnings Date10/29/2020 (Estimated)
OptionableOptionable
$6.94
+0.09 (+1.31 %)
(As of 08/7/2020 04:00 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive ULBI News and Ratings via Email

Sign-up to receive the latest news and ratings for ULBI and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Ultralife (NASDAQ:ULBI) Frequently Asked Questions

How has Ultralife's stock been impacted by COVID-19 (Coronavirus)?

Ultralife's stock was trading at $6.44 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, ULBI stock has increased by 7.8% and is now trading at $6.94.
View which stocks have been most impacted by Coronavirus
.

When is Ultralife's next earnings date?

Ultralife is scheduled to release its next quarterly earnings announcement on Thursday, October 29th 2020.
View our earnings forecast for Ultralife
.

How were Ultralife's earnings last quarter?

Ultralife Corp. (NASDAQ:ULBI) released its quarterly earnings data on Thursday, August, 2nd. The technology company reported $0.10 earnings per share (EPS) for the quarter. The technology company earned $22.86 million during the quarter. Ultralife had a return on equity of 5.87% and a net margin of 4.64%.
View Ultralife's earnings history
.

How will Ultralife's stock buyback program work?

Ultralife declared that its board has authorized a share repurchase plan on Thursday, November 1st 2018, which authorizes the company to repurchase 2,500,000 outstanding shares, according to EventVestor. This repurchase authorization authorizes the company to repurchase shares of its stock through open market purchases. Stock repurchase plans are usually a sign that the company's board believes its shares are undervalued.

Has Ultralife been receiving favorable news coverage?

Media headlines about ULBI stock have been trending very positive this week, according to InfoTrie Sentiment Analysis. The research group identifies negative and positive media coverage by analyzing more than six thousand news and blog sources in real-time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Ultralife earned a news sentiment score of 4.0 on InfoTrie's scale. They also assigned media stories about the technology company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an impact on the stock's share price in the immediate future.
View the latest news about Ultralife
.

Are investors shorting Ultralife?

Ultralife saw a decrease in short interest in the month of July. As of July 31st, there was short interest totaling 179,900 shares, a decrease of 11.3% from the July 15th total of 202,900 shares. Based on an average trading volume of 54,400 shares, the days-to-cover ratio is currently 3.3 days. Currently, 1.8% of the company's stock are sold short.
View Ultralife's Current Options Chain
.

Who are some of Ultralife's key competitors?

What other stocks do shareholders of Ultralife own?

Who are Ultralife's key executives?

Ultralife's management team includes the following people:
  • Mr. Michael D. Popielec, CEO, Pres & Director (Age 57)
  • Mr. Philip A. Fain, CFO, Treasurer & Corp. Sec. (Age 64)

What is Ultralife's stock symbol?

Ultralife trades on the NASDAQ under the ticker symbol "ULBI."

Who are Ultralife's major shareholders?

Ultralife's stock is owned by a number of institutional and retail investors. Top institutional investors include Russell Investments Group Ltd. (3.69%) and New York State Common Retirement Fund (0.09%). Company insiders that own Ultralife stock include Bradford T Whitmore, Philip A Fain, Thomas Louis Saeli and W Shaw Robert.
View institutional ownership trends for Ultralife
.

Which institutional investors are buying Ultralife stock?

ULBI stock was purchased by a variety of institutional investors in the last quarter, including Russell Investments Group Ltd., and New York State Common Retirement Fund. Company insiders that have bought Ultralife stock in the last two years include Bradford T Whitmore, Philip A Fain, Thomas Louis Saeli, and W Shaw Robert.
View insider buying and selling activity for Ultralife
.

How do I buy shares of Ultralife?

Shares of ULBI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Ultralife's stock price today?

One share of ULBI stock can currently be purchased for approximately $6.94.

How big of a company is Ultralife?

Ultralife has a market capitalization of $110.30 million and generates $106.79 million in revenue each year.

What is Ultralife's official website?

The official website for Ultralife is www.ultralifecorporation.com.

How can I contact Ultralife?

Ultralife's mailing address is 2000 TECHNOLOGY PARKWAY, NEWARK NY, 14513. The technology company can be reached via phone at 315-332-7100.

This page was last updated on 8/8/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.